• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过激光辅助显微切割和定量实时聚合酶链反应检测导管内和浸润性乳腺癌中的基因扩增

Detection of gene amplification in intraductal and infiltrating breast cancer by laser-assisted microdissection and quantitative real-time PCR.

作者信息

Glöckner S, Lehmann U, Wilke N, Kleeberger W, Länger F, Kreipe H

机构信息

Institute of Pathology, Medizinische Hochschule Hannover, Germany.

出版信息

Pathobiology. 2000;68(4-5):173-9. doi: 10.1159/000055920.

DOI:10.1159/000055920
PMID:11279343
Abstract

Gene amplification is one essential mechanism leading to oncogene activation which is supposed to play a major role in the pathogenesis of invasive breast cancer. However, using standard methodologies the detection of gene amplifications has been limited especially in small-sized lesions, like pre-invasive precursor lesions. The combination of two novel technologies, laser-based microdissection and quantitative real-time PCR, facilitates the detection of low-level amplifications in morphologically defined lesions. As a model system we investigated in situ breast cancer (ductal carcinoma in situ, DCIS) classified according to the morphology-based Van Nuys grading system for amplification of growth-regulatory genes. In this study 83 formalin-fixed, paraffin-embedded archival DCIS specimens were examined after laser-based microdissection by quantitative real-time PCR using the TaqMan detection system for amplification of the c-erbB2, topoisomerase IIalpha, c-myc and cyclinD1 gene. In a subset of 17 DCIS with adjacent infiltrating tumour components we compared intraductal and invasive tumour components in parallel for differences in amplification status. The combination of these new techniques represents an excellent tool to gain new insights into carcinogenesis by analyzing genetic alterations in morphologically identified heterogeneous lesions in breast cancer progression within the very same specimen or even tissue slide.

摘要

基因扩增是导致癌基因激活的一种重要机制,被认为在浸润性乳腺癌的发病机制中起主要作用。然而,使用标准方法检测基因扩增一直受到限制,尤其是在小尺寸病变中,如浸润前的前驱病变。激光显微切割和定量实时PCR这两种新技术的结合,有助于在形态学明确的病变中检测低水平扩增。作为一个模型系统,我们研究了根据基于形态学的Van Nuys分级系统分类的原位乳腺癌(导管原位癌,DCIS)中生长调节基因的扩增情况。在本研究中,使用TaqMan检测系统对83个福尔马林固定、石蜡包埋的存档DCIS标本进行激光显微切割后,通过定量实时PCR检测c-erbB2、拓扑异构酶IIα、c-myc和细胞周期蛋白D1基因的扩增。在17个伴有相邻浸润性肿瘤成分的DCIS子集中,我们平行比较了导管内和浸润性肿瘤成分的扩增状态差异。这些新技术的结合是一种极好的工具,通过分析同一标本甚至组织切片中乳腺癌进展过程中形态学确定的异质性病变中的基因改变,来深入了解致癌作用。

相似文献

1
Detection of gene amplification in intraductal and infiltrating breast cancer by laser-assisted microdissection and quantitative real-time PCR.通过激光辅助显微切割和定量实时聚合酶链反应检测导管内和浸润性乳腺癌中的基因扩增
Pathobiology. 2000;68(4-5):173-9. doi: 10.1159/000055920.
2
Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness.导管内乳腺癌中生长调节基因的扩增与较高的核分级相关,但与侵袭性进展无关。
Lab Invest. 2001 Apr;81(4):565-71. doi: 10.1038/labinvest.3780265.
3
Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction.通过激光辅助显微切割和定量实时聚合酶链反应检测存档乳腺癌标本中的基因扩增
Am J Pathol. 2000 Jun;156(6):1855-64. doi: 10.1016/S0002-9440(10)65059-6.
4
Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma.浸润性癌旁乳腺导管内病变中的异质性染色体畸变。
Anal Cell Pathol. 2000;20(1):17-24. doi: 10.1155/2000/930246.
5
Gene amplification in ductal carcinoma in situ of the breast.乳腺导管原位癌中的基因扩增。
Breast Cancer Res Treat. 2010 Oct;123(3):757-65. doi: 10.1007/s10549-009-0675-8. Epub 2009 Dec 22.
6
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.有证据表明,在乳腺导管癌进展过程中,细胞的分子变化先于形态学改变出现。
Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17.
7
Detection of CHK1 and CCND1 gene copy number changes in breast cancer with dual-colour fluorescence in-situ hybridization.应用双色荧光原位杂交技术检测乳腺癌中 CHK1 和 CCND1 基因拷贝数的变化。
Histopathology. 2011 Mar;58(4):601-7. doi: 10.1111/j.1365-2559.2011.03780.x. Epub 2011 Mar 14.
8
Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.在包含匹配的导管原位癌和浸润性导管乳腺癌的福尔马林固定和石蜡包埋组织中鉴定出的具有特定进展阶段的基因。
BMC Med Genomics. 2018 Sep 20;11(1):80. doi: 10.1186/s12920-018-0403-5.
9
Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.细胞周期蛋白D1在原发性乳腺癌中的表达与扩增:与组织病理学类型及临床病理参数的关系
Oncol Rep. 2002 Mar-Apr;9(2):409-16.
10
Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIalpha genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization.使用杂交探针的定量实时聚合酶链反应和荧光原位杂交技术对乳腺癌中的c-erb-B2(HER-2/neu)和拓扑异构酶IIα基因进行拷贝数分析。
Arch Pathol Lab Med. 2005 Jan;129(1):39-46. doi: 10.5858/2005-129-39-CNAOCN.

引用本文的文献

1
In Silico cancer cell versus stroma cellularity index computed from species-specific human and mouse transcriptome of xenograft models: towards accurate stroma targeting therapy assessment.从异种移植模型的物种特异性人类和小鼠转录组计算的计算机模拟癌细胞与基质细胞密度指数:迈向准确的基质靶向治疗评估。
BMC Med Genomics. 2014;7 Suppl 1(Suppl 1):S2. doi: 10.1186/1755-8794-7-S1-S2. Epub 2014 May 8.
2
Laser capture microdissection and advanced molecular analysis of human breast cancer.人类乳腺癌的激光捕获显微切割及先进分子分析
J Mammary Gland Biol Neoplasia. 2003 Jul;8(3):335-45. doi: 10.1023/b:jomg.0000010033.49464.0c.
3
c-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate, and how significant?
c-myc而非her-2/neu能够预测乳腺癌患者的预后:有多新颖、多准确以及多重要?
Breast Cancer Res. 2003;5(4):188-91. doi: 10.1186/bcr606. Epub 2003 Apr 24.